About acute myocardial infarction

OP2113 for the treatment of acute myocardial infarction

The persistence of ischemic heart disease as a major cause of global mortality and morbidity despite major therapeutic advances in this area, along with an evolving understanding of the reperfusion injury itself, has led to a focus on novel therapies to limit myocardial injury and facilitate myocardial recovery following acute myocardial infarction. Prevention of these reperfusion injuries by pharmacological approach is still lacking to date.

  • OP2drugs
  • Expertise & CSO position
  • January 26th, 2018